ArticleMarine drugs2022
Rapid Mining of Novel
Jianlin Xu, Zhifeng Liu, Zhanguang Feng, Yuhong Ren, Haili Liu, Yong Wang
Abstract read
In one paragraphArticle in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Jianlin XuState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.
Zhifeng LiuCAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai 200032, China.
Zhanguang FengCAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai 200032, China.
Yuhong RenState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.
Haili LiuCAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai 200032, China.
Yong WangState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.
Funding
Construction of the Registry and Database of Bioparts for Synthetic Biology of Chinese Academy of Sciences ZSYS-016International Partnership Program of Chinese Academy of Sciences 153D31KYSB20170121National Key R&D Program of China 2018YFA0900600National Natural Science Foundation of China 41876084, 31670099Program of Shanghai Academic Research Leader 20XD1404400Strategic Priority Research Program "Molecular mechanism of Plant Growth and Development" of Chinese Academy of Sciences XDB27020202, XDB27020103Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project TSBICIP-KJGG-002-15
6 · The paper itselfAbstract
A rapid and sensitive method using ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS/MS) was applied for the analysis of the metabolic profile of acarviostatin-containing aminooligosaccharides derived from
Indexed as
alpha-GlucosidasesChromatography, High Pressure LiquidGlycoside Hydrolase InhibitorsLipaseOligosaccharidesPancreatic alpha-AmylasesStreptomycesSucraseTandem Mass Spectrometryalpha-GlucosidasesGlycoside Hydrolase InhibitorsLipaseOligosaccharidesPancreatic alpha-AmylasesSucraseaminooligosaccharidesdiabetesdigestive enzyme inhibitorsmetabolic profilingStreptomyces sp. HO1518UPLC-QTOF-MS/MS
Identifiers
PMID35323488
PMCPMC8955712
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390